207 related articles for article (PubMed ID: 36334860)
1. The past, present, and future of chemotherapy with a focus on individualization of drug dosing.
DeRidder L; Rubinson DA; Langer R; Traverso G
J Control Release; 2022 Dec; 352():840-860. PubMed ID: 36334860
[TBL] [Abstract][Full Text] [Related]
2. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology.
Erku D; Schneider J; Scuffham P
Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the utility of therapeutic drug monitoring in the clinical use of small molecule kinase inhibitors: a review of the literature.
Fahmy A; Hopkins AM; Sorich MJ; Rowland A
Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):803-821. PubMed ID: 34278936
[No Abstract] [Full Text] [Related]
4. [Role of individualized dosing in oncology: are we there yet?].
Joerger M
Praxis (Bern 1994); 2013 Dec; 103(1):33-9. PubMed ID: 24393821
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring in cancer--are we missing a trick?
Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
[TBL] [Abstract][Full Text] [Related]
6. Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
Groenland SL; Mathijssen RHJ; Beijnen JH; Huitema ADR; Steeghs N
Eur J Clin Pharmacol; 2019 Sep; 75(9):1309-1318. PubMed ID: 31175385
[TBL] [Abstract][Full Text] [Related]
7. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
[TBL] [Abstract][Full Text] [Related]
8. Current status and future outlooks on therapeutic drug monitoring of fluorouracil.
Schmulenson E; Zimmermann N; Mikus G; Joerger M; Jaehde U
Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1407-1422. PubMed ID: 35029518
[TBL] [Abstract][Full Text] [Related]
9. Precision Dosing of Targeted Therapies Is Ready for Prime Time.
Groenland SL; Verheijen RB; Joerger M; Mathijssen RHJ; Sparreboom A; Beijnen JH; Beumer JH; Steeghs N; Huitema ADR
Clin Cancer Res; 2021 Dec; 27(24):6644-6652. PubMed ID: 34548319
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review.
Thimotheo Batista JP; Santos Marzano LA; Menezes Silva RA; de Sá Rodrigues KE; Simões E Silva AC
Curr Med Chem; 2023; 30(9):1003-1028. PubMed ID: 35946096
[TBL] [Abstract][Full Text] [Related]
11. Closed-loop automated drug infusion regulator: A clinically translatable, closed-loop drug delivery system for personalized drug dosing.
DeRidder LB; Hare KA; Lopes A; Jenkins J; Fitzgerald N; MacPherson E; Fabian N; Morimoto J; Chu JN; Kirtane AR; Madani W; Ishida K; Kuosmanen JLP; Zecharias N; Colangelo CM; Huang HW; Chilekwa M; Lal NB; Srinivasan SS; Hayward AM; Wolpin BM; Trumper D; Quast T; Rubinson DA; Langer R; Traverso G
Med; 2024 Apr; ():. PubMed ID: 38663403
[TBL] [Abstract][Full Text] [Related]
12. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
13. Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice.
Wilhelm M; Mueller L; Miller MC; Link K; Holdenrieder S; Bertsch T; Kunzmann V; Stoetzer OJ; Suttmann I; Braess J; Birkmann J; Roessler M; Moritz B; Kraff S; Salamone SJ; Jaehde U
Clin Colorectal Cancer; 2016 Dec; 15(4):381-388. PubMed ID: 27256667
[TBL] [Abstract][Full Text] [Related]
14. Applications and challenges in therapeutic drug monitoring of cancer treatment: A review.
Salman B; Al-Khabori M
J Oncol Pharm Pract; 2021 Apr; 27(3):693-701. PubMed ID: 33302823
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
Salas S; Mercier C; Ciccolini J; Pourroy B; Fanciullino R; Tranchand B; Monjanel-Mouterde S; Baciuchka-Palmaro M; Dupuis C; Yang C; Balti M; Lacarelle B; Duffaud F; Durand A; Favre R
Ther Drug Monit; 2006 Aug; 28(4):532-9. PubMed ID: 16885721
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel.
Andriguetti NB; Raymundo S; Antunes MV; Perassolo MS; Verza SG; Suyenaga ES; Linden R
Curr Med Chem; 2017; 24(33):3559-3582. PubMed ID: 28641556
[TBL] [Abstract][Full Text] [Related]
17. Dose calculation of anticancer drugs.
Gao B; Klumpen HJ; Gurney H
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1307-19. PubMed ID: 18798700
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.
Groenland SL; van Eerden RAG; Westerdijk K; Meertens M; Koolen SLW; Moes DJAR; de Vries N; Rosing H; Otten H; Vulink AJE; Desar IME; Imholz ALT; Gelderblom H; van Erp NP; Beijnen JH; Mathijssen RHJ; Huitema ADR; Steeghs N;
Ann Oncol; 2022 Oct; 33(10):1071-1082. PubMed ID: 35777707
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of 5-fluorouracil.
Lee JJ; Beumer JH; Chu E
Cancer Chemother Pharmacol; 2016 Sep; 78(3):447-64. PubMed ID: 27217046
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in Oncology.
Groenland SL; van Nuland M; Verheijen RB; Schellens JHM; Beijnen JH; Huitema ADR; Steeghs N
Clin Pharmacokinet; 2019 Mar; 58(3):299-308. PubMed ID: 29862467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
